Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

MOSBY-ELSEVIER

1. NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024980, UL1RR024979] Funding Source: NIH RePORTER
2. Veterans Affairs [I01CX000317] Funding Source: NIH RePORTER
3. VA [5I01CX000317-02] Funding Source: Federal RePORTER
4. NCRR NIH HHS [KL2 RR024980, UL1 RR024979, 1UL1RR024979] Funding Source: Medline
5. CSRD VA [I01 CX000317] Funding Source: Medline